FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/103374 [Registered on: 09/02/2026] Trial Registered Prospectively
Last Modified On: 06/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   A Hospital-Based Study on Delays in Cancer Diagnosis and Treatment among Adult Patients from Different Social and Demographic Backgrounds 
Scientific Title of Study   Socio-demographic Disparities and Delays in diagnosis and treatment of Cancer Cases: A Cross-Sectional Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Raajdhruv Bansal 
Designation  Student 
Affiliation  Manipal Academy of Higher Education 
Address  Department of Healthcare and Hospital Management Prasanna School of Public Health, MAHE Manipal, Karnataka - 576104

Udupi
KARNATAKA
576104
India 
Phone  8171774200  
Fax    
Email  raajdhruv.bansal22@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Swathi KS 
Designation  Professor, Guide. 
Affiliation  Manipal Academy of Higher Education 
Address  Department of Healthcare and Hospital Management Prasanna School of Public Health, MAHE Manipal, Karnataka - 576104

Udupi
KARNATAKA
576104
India 
Phone  9481749911  
Fax    
Email  swathi.ks@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Swathi KS 
Designation  Professor, Guide. 
Affiliation  Manipal Academy of Higher Education 
Address  Department of Healthcare and Hospital Management Prasanna School of Public Health, MAHE Manipal, Karnataka - 576104

Udupi
KARNATAKA
576104
India 
Phone  9481749911  
Fax    
Email  swathi.ks@manipal.edu  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Raajdhruv Bansal 
Address  Department of Healthcare and Hospital Management Prasanna School of Public Health, MAHE Manipal, Karnataka - 576104 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Raajdhruv Bansal  OPD Waiting Area of ShirdiSai Baba Cancer Hospital, Manipal  ShirdiSai Baba Cancer Hospital and Research Centre at Kasturba Medical College (KMC), MANIPAL, UDUPI.
Udupi
KARNATAKA 
08171774200

raajdhruv.bansal22@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee - 2  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: D499||Neoplasm of unspecified behavior of unspecified site,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1. Adult cancer patients above 18 years
2. Patients attending oncology outpatient services
3. Patients deemed suitable for participation by the treating oncologist
 
 
ExclusionCriteria 
Details  •Patients below 18 years of age
•Patients unwilling to participate
•Patients for whom participation is not advised by the treating oncologist
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
•Identification of socio-demographic groups at higher risk of delayed diagnosis and treatment
•Identification of key social and health-system barriers contributing to delays
•Quantification of treatment delays across socio-demographic strata
•Evidence-based recommendations to reduce delays in cancer care
•All outcomes in this study are descriptive and analytical process outcomes related to diagnosis and treatment timelines.
 
1 year 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="384"
Sample Size from India="384" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   23/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Cancer is a major public health problem in India and many patients experience delays in diagnosis and initiation of treatment. These delays are often influenced by socio demographic factors social barriers and health system related issues which can lead to advanced stage presentation and poorer outcomes. Understanding these factors is essential for improving timely access to cancer care and reducing inequalities.

This study is an observational prospective cross sectional study conducted among adult cancer patients attending the oncology outpatient department of Shirdi Sai Baba Cancer Hospital and Research Centre Kasturba Medical College Manipal. Eligible patients above 18 years of age will be recruited after obtaining informed consent. Data will be collected once during the outpatient visit using a structured questionnaire to capture socio demographic details health seeking behaviour and perceived barriers to care. Clinical information including cancer diagnosis stage and treatment initiation dates will be obtained from hospital records wherever available.

The study aims to assess the association between socio demographic factors and stage at diagnosis to identify factors contributing to delays in cancer treatment and to examine disparities in access to cancer care and treatment intent. The findings of this study are expected to provide evidence on key social and system level barriers affecting timely cancer care and to support recommendations for reducing delays and improving equitable access to cancer services.

 

 
Close